S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Forget NVDA. Buy this A.I. stock instead (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Tentative deal reached to end the Hollywood writers strike. No deal yet for actors
His system isolated NVIDIA - Here's His Next Buy. (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Forget NVDA. Buy this A.I. stock instead (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Tentative deal reached to end the Hollywood writers strike. No deal yet for actors
His system isolated NVIDIA - Here's His Next Buy. (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Forget NVDA. Buy this A.I. stock instead (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Tentative deal reached to end the Hollywood writers strike. No deal yet for actors
His system isolated NVIDIA - Here's His Next Buy. (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Forget NVDA. Buy this A.I. stock instead (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Tentative deal reached to end the Hollywood writers strike. No deal yet for actors
His system isolated NVIDIA - Here's His Next Buy. (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
OTCMKTS:KALTF

Claritas Pharmaceuticals (KALTF) Stock Forecast, Price & News

Compare
Today's Range
N/A
50-Day Range
$0.00
$0.08
52-Week Range
N/A
Volume
N/A
Average Volume
9,705 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

KALTF stock logo

About Claritas Pharmaceuticals (OTCMKTS:KALTF) Stock

Claritas Pharmaceuticals, Inc. engages in the development of next generation cannabinoid therapeutics. It also offers development programs for bone fracture healing, osteogenesis imperfecta, osteoporosis, and osteoporosis in Prader-Willi syndrome. The company was founded by Seth Yakatan on October 15, 2004 and is headquartered in San Rafael, CA.


KALTF Stock News Headlines

DPHAY - Dechra Pharmaceuticals PLC
WARNING: Mandatory U.S. Dollar Recall is Weeks Away
If you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.
ACXP - Acurx Pharmaceuticals, Inc.
WARNING: Mandatory U.S. Dollar Recall is Weeks Away
If you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.
Claritas Pharmaceuticals, Inc. (CLAZF)
Claritas Pharmaceuticals Inc
Claritas Pharmaceuticals Inc (CLAS)
See More Headlines
Receive KALTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Claritas Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

KALTF Company Calendar

Last Earnings
11/29/2013
Today
9/24/2023

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:KALTF
Previous Symbol
OTCMKTS:QUEZF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Robert Edward Farrell
    Chairman, President & Chief Executive Officer
  • Victoria Diana Rudman
    Chief Financial Officer, Secretary & Treasurer
  • Nedira Frenkel
    Director-Business Development













KALTF Stock - Frequently Asked Questions

How were Claritas Pharmaceuticals' earnings last quarter?

Claritas Pharmaceuticals, Inc. (OTCMKTS:KALTF) issued its quarterly earnings data on Friday, November, 29th. The company reported ($0.40) EPS for the quarter.

When did Claritas Pharmaceuticals' stock split?

Claritas Pharmaceuticals shares reverse split on the morning of Friday, July 23rd 2021. The 1-20 reverse split was announced on Friday, July 23rd 2021. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 23rd 2021. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What is Claritas Pharmaceuticals' stock symbol?

Claritas Pharmaceuticals trades on the OTCMKTS under the ticker symbol "KALTF."

How do I buy shares of Claritas Pharmaceuticals?

Shares of KALTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How can I contact Claritas Pharmaceuticals?

Claritas Pharmaceuticals' mailing address is 4040 Civic Center Drive, San Rafael, CA 94903. The official website for the company is kalytera.co. The company can be reached via phone at (888) 861-2008.

This page (OTCMKTS:KALTF) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -